The treatment that President Donald Trump has received to fight COVID-19 has turned the focus on an experimental drug that shows promise in combating the coronavirus but is raising ethical questions about the cell line that helped researchers develop the medicine.
It's Happening: I've made several visits, curiosity-driven, to the Georgetown medical school's anatomy labs during dissections. And one day, my own cadaver will be wheeled in to help future doctors learn.
The revelation in late November that a Chinese researcher had edited genes in human embryos and then implanted them in a woman was "a train wreck of a thing to do," said an ethicist at the National Catholic Bioethics Center in Philadelphia.
Religious and indigenous leaders from 21 countries gathered in Norway June 19 to launch a new initiative aimed at saving the world's tropical rainforests from the impact of deforestation and climate change.